L-655,708: Difference between revisions
CSV import |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 21: | Line 21: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:L-655,708.svg|L-655,708 | |||
</gallery> | |||
Latest revision as of 00:23, 17 March 2025
L-655,708 is a drug that acts as a selective inverse agonist of the alpha-5 subunit of the GABAA receptor. It is used in scientific research and has no medical use in humans, but is legal for use in research settings.
Pharmacology[edit]
L-655,708 is a selective inverse agonist of the alpha-5 subunit of the GABAA receptor, which is a subtype of the GABAA receptor that is expressed in high levels in the hippocampus and related areas of the brain. This makes it useful for research into the role of this receptor subtype in learning, memory, and other cognitive functions.
Uses[edit]
L-655,708 is used in scientific research to investigate the role of the alpha-5 subunit of the GABAA receptor in various processes. It has been used in studies investigating the role of this receptor subtype in learning and memory, and has also been used to investigate the potential for drugs targeting this receptor subtype to be used in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia.
Side Effects[edit]
As a research chemical, L-655,708 is not used in humans and therefore its side effects are not well known. However, as an inverse agonist of the GABAA receptor, it is likely to have similar side effects to other drugs that modulate this receptor, such as anxiety, insomnia, and potentially seizures in high doses.
